Espresso Capital

Espresso Capital structures loans based on recurring revenue or annual recurring revenue (ARR) rather than hard collateral like real estate or equipment. This allows software and services companies with minimal tangible assets but predictable revenue streams to access debt financing. Terms often include revenue-based repayment schedules rather than fixed amortization.

The firm targets early- to growth-stage technology companies in North America that have achieved product-market fit and generate recurring revenue. Sectors include FinTech, Enterprise Software, Digital Health, ClimateTech, and AI/ML. Companies typically have between $1M and $10M in ARR and are raising Series A through C equity rounds.

Espresso Capital primarily provides venture debt, but may structure deals that include warrants or equity kickers. The firm's core product is non-dilutive capital, meaning it does not typically take board seats or require majority ownership. This structure appeals to founders seeking to minimize dilution while extending runway.

Loan sizes are not publicly disclosed, but venture debt facilities for companies at the stage Espresso Capital targets typically range from $1M to $10M. The specific amount depends on the borrower's recurring revenue, growth rate, and existing equity capital.

The firm likely sources opportunities through referrals from venture capital firms, angel investors, and startup accelerators in the Toronto-Waterloo corridor and other North American tech hubs. Venture debt is often introduced by a company's lead equity investor. Publicly, the firm maintains a website at espressocapital.com.

No. Espresso Capital operates as a specialty finance firm and asset manager, not a single family office. The firm's capital likely comes from institutional investors, high-net-worth individuals, or a dedicated fund vehicle, though its legal structure is not publicly specified.

Based on its focus on recurring-revenue technology companies, Espresso Capital likely avoids hardware-intensive sectors, real estate, biotech, and traditional manufacturing or service businesses. The firm's underwriting model depends on predictable software or subscription revenue, so asset-heavy or lumpy-revenue businesses are generally not a fit.